Table 1.

General demographic features of 405 patients with systemic sclerosis (SSc). Values are median ± SE of the mean. Nine patients who were lost to followup were excluded from survival or standardized mortality ratio analyses.

CharacteristicAll PatientsSurviving Patients, n (%)Dead Patients, n (%)p
No. patients405310 (76.5)86 (21.2)
Men, n (%)29 (7.2)19 (6.1)9 (10.5)0.1616
dcSSc, n (%)132 (32.6)86 (27.7)46 (53.5)< 0.0001
Age at onset, yrs (range)47 ± 0.7 (5–78)47 ± 1.6 (5–78)47 ± 0.8 (9–73)0.9029
Onset to diagnosis, yrs (range)2 ± 0.4 (0–44)2 ± 0.5 (0–44)3 ± 0.7 (0–35)0.6290
Disease duration, yrs (range)14 ± 0.6 (1–59)15 ± 0.7 (1–59)11 ± 1.2 (1–57)0.0230
Organ involvement
  GI tract187137 (44.2)49 (57.0)0.0356
  Lung204125 (40.3)75 (87.2)< 0.0001
  Heart7935 (11.3)43 (50.0)< 0.0001
  Kidney6034 (11.0)25 (29.1)0.0001
  Scleroderma renal crisis136 (1.9)7 (8.1)0.0100
  Pulmonary arterial hypertension6536 (11.6)27 (31.4)< 0.0001
Overlap of connective tissue disease
  Systemic lupus erythematosus2118 (5.8)3 (3.5)0.5870
  Rheumatoid arthritis1915 (4.8)4 (4.7)1.0000
  Sjögren’s syndrome5148 (15.5)3 (3.5)0.0018
  Myositis2213 (4.2)8 (9.3)0.0970
  • DcSSc: diffuse cutaneous systemic sclerosis; GI: gastrointestinal.